Joseph J. Belanto

3.3k citations

14 papers · 2.3k indexed · 2 hit papers · h-index 12

Molecular Biology top 5%
Plant Science top 5%
Genetics top 10%
Cardiology and Cardiovascular Medicine top 10%
Cancer Research top 10%

Co-authors: Daniel F. Voytas Eric S. Lander Omar O. Abudayyeh Shuo Han David Cox Jonathan S. Gootenberg Vanessa K. Verdine Aviv Regev
Topics: Muscle Physiology and Disorders (11 papers)Cardiomyopathy and Myosin Studies (6 papers)Genetic Neurodegenerative Diseases (4 papers)
Cited by: Business and International Management Aging Molecular Biology
Journals: Nature Proceedings of the National Academy of Sciences Nature Communications
Partner nations: United States Russia France

In The Last Decade

Joseph J. Belanto

14 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNA targeting with CRISPR–Cas13

2017 1.5k citations Omar O. Abudayyeh, Jonathan S. Gootenberg et al. Nature profile →
A Multipurpose Toolkit to Enable Advanced Genome Engineering in Plants

2017 454 citations Tomáš Čermák, Shaun J. Curtin et al. The Plant Cell profile →

Peers

Countries citing papers authored by Joseph J. Belanto

Since Specialization

Citations

This map shows the geographic impact of Joseph J. Belanto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Belanto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Belanto more than expected).

Fields of papers citing papers by Joseph J. Belanto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph J. Belanto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Belanto. The network helps show where Joseph J. Belanto may publish in the future.

Co-authorship network of co-authors of Joseph J. Belanto

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Belanto. A scholar is included among the top collaborators of Joseph J. Belanto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Belanto. Joseph J. Belanto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Loss of peroxiredoxin-2 exacerbates eccentric contraction-induced force loss in dystrophin-deficient muscle 2018 ·Nature Communications ·(unknown),Angus Lindsay,Reem Abo‐Zahrah,Kristen A. Baltgalvis,(unknown),Joseph J. Belanto,(unknown),Benjamin J. Perrin,Daniel J. Garry,George G. Rodney,Dawn A. Lowe,James M. Ervasti	30
2	Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle 2018 ·Human Molecular Genetics ·Davide Randazzo,(unknown),Joseph J. Belanto,(unknown),(unknown),(unknown),(unknown),Kristien J.M. Zaal,Katherine Pak,Iago Pinal‐Fernandez,Andrew L. Mammen,Dan L. Sackett,James M. Ervasti,Evelyn Ralston	34
3	A Multipurpose Toolkit to Enable Advanced Genome Engineering in Plantsbreakdown → 2017 ·The Plant Cell ·Tomáš Čermák,Shaun J. Curtin,Javier Gil‐Humanes,Radim Čegan,Thomas J. Y. Kono,(unknown),Joseph J. Belanto,Colby G. Starker,(unknown),(unknown),Daniel F. Voytas	454
4	RNA targeting with CRISPR–Cas13breakdown → 2017 ·Nature ·Omar O. Abudayyeh,Jonathan S. Gootenberg,Patrick Essletzbichler,Shuo Han,Julia Joung,Joseph J. Belanto,Vanessa K. Verdine,David Cox,Max J. Kellner,Aviv Regev,Eric S. Lander,Daniel F. Voytas,Alice Y. Ting,Feng Zhang	1490
5	Mouse models of two missense mutations in actin-binding domain 1 of dystrophin associated with Duchenne or Becker muscular dystrophy 2017 ·Human Molecular Genetics ·(unknown),(unknown),Angus Lindsay,Robert W. Arpke,(unknown),(unknown),Christopher M. Chamberlain,(unknown),Joseph J. Belanto,(unknown),Michael Kyba,Dawn A. Lowe,James M. Ervasti	15
6	Gene editing and its application for hematological diseases 2016 ·International Journal of Hematology ·Mark J. Osborn,Joseph J. Belanto,Jakub Tolar,Daniel F. Voytas	25
7	Independent variability of microtubule perturbations associated with dystrophinopathy 2016 ·Human Molecular Genetics ·Joseph J. Belanto,(unknown),Tara L. Mader,Christopher M. Chamberlain,(unknown),(unknown),(unknown),Gregg G. Gundersen,Dawn A. Lowe,James M. Ervasti	38
8	In vitro stability of therapeutically relevant, internally truncated dystrophins 2015 ·Skeletal Muscle ·(unknown),(unknown),(unknown),Joseph J. Belanto,(unknown),James M. Ervasti	14
9	Creatine kinase B is necessary to limit myoblast fusion during myogenesis 2015 ·American Journal of Physiology-Cell Physiology ·(unknown),Christophe Pichavant,James P. Canner,Luciano H. Apponi,Yanru Wang,(unknown),(unknown),Joseph J. Belanto,James M. Ervasti,Grace K. Pavlath	11
10	Pax3-induced expansion enables the genetic correction of dystrophic satellite cells 2015 ·Skeletal Muscle ·Antonio Filareto,Fabrizio Rinaldi,Robert W. Arpke,Radbod Darabi,Joseph J. Belanto,Erik A. Toso,(unknown),James M. Ervasti,R. Scott McIvor,Michael Kyba,Rita C. R. Perlingeiro	11
11	Disease-proportional proteasomal degradation of missense dystrophins 2015 ·Proceedings of the National Academy of Sciences ·(unknown),Joseph J. Belanto,James M. Ervasti	20
12	Microtubule binding distinguishes dystrophin from utrophin 2014 ·Proceedings of the National Academy of Sciences ·Joseph J. Belanto,Tara L. Mader,Michael D. Eckhoff,(unknown),Glen B. Banks,Melissa K. Gardner,Dawn A. Lowe,James M. Ervasti	110
13	Internal deletion compromises the stability of dystrophin 2011 ·Human Molecular Genetics ·Davin M. Henderson,Joseph J. Belanto,Bin Li,Hanke Heun‐Johnson,James M. Ervasti	32
14	Dexamethasone induces dysferlin in myoblasts and enhances their myogenic differentiation 2010 ·Neuromuscular Disorders ·Joseph J. Belanto,(unknown),Clara E. Magyar,Michele M. Maxwell,(unknown),(unknown),(unknown),Catriona Jamieson,Nicholas A. Cacalano,(unknown),(unknown)	43

About Joseph J. Belanto

Joseph J. Belanto is a scholar working on Business and International Management, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience, having authored 14 papers that have together received 2.3k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (11 papers), Cardiomyopathy and Myosin Studies (6 papers) and Genetic Neurodegenerative Diseases (4 papers). The work is most often cited by research in Business and International Management (160 citations), Aging (84 citations) and Molecular Biology (2.2k citations). Joseph J. Belanto has collaborated with scholars based in United States, Russia and France. Frequent co-authors include Daniel F. Voytas, Eric S. Lander, Omar O. Abudayyeh, Shuo Han, David Cox, Jonathan S. Gootenberg, Vanessa K. Verdine, Aviv Regev, Alice Y. Ting and Julia Joung. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact